
Nephrologist

No OPD information available
Kidney Transplant
Chronic Kidney Disease
Diabetic Nephropathy
End-Stage Renal Disease (ESRD)
ABO Incompatibility
Actinic Keratosis
Colonoscopy
Colorectal Cancer
Coronary Heart Disease
COVID-19
Focal Segmental Glomerulosclerosis
Glomerulonephritis
High Potassium Level
Hypertension
IgA Nephropathy
Interstitial Nephritis
Metabolic Acidosis
Minimal Change Disease
Nephrectomy
Nephrotic Syndrome
Obesity
Obesity Hypoventilation Syndrome (OHS)
Peripheral Neuropathy
Severe Acute Respiratory Syndrome (SARS)
Tongue Cancer
Type 2 Diabetes (T2D)
Wilson Disease
Steven J. Chadban is a doctor who helps people with kidney problems like kidney transplants, chronic kidney disease, and diabetic kidney issues. He also treats conditions like high potassium levels, hypertension, and heart disease. Steven J. Chadban is skilled in treating various kidney diseases like glomerulonephritis and nephrotic syndrome. He also helps patients with diabetes, obesity, and other health concerns.
Steven J. Chadban talks to his patients in a way that they can understand, making them feel comfortable and cared for. Patients trust him because he listens to their concerns and explains things clearly. He uses his knowledge and experience to provide the best care possible.
To stay updated with the latest medical information, Steven J. Chadban reads research studies and attends conferences. This helps him offer the most advanced treatments to his patients. He works closely with other medical professionals to ensure his patients receive comprehensive care.
Steven J. Chadban's work has had a positive impact on many patients' lives. His research study, the CKD Stewardship study, aims to improve the early detection and management of chronic kidney disease. He has also been involved in clinical trials to find better treatments for kidney transplant recipients.
One of Steven J. Chadban's notable publications is about the importance of early detection in chronic kidney disease. He has also been part of a clinical trial evaluating a new treatment for kidney transplant patients. His dedication to improving patient care and advancing medical knowledge shows his commitment to helping people live healthier lives.
Enrollment Status: Terminated
Published: April 24, 2024
Intervention Type: Drug, Biological
Study Drug:
Study Phase: Phase 3
